Discover the Visian ICL

ICL Overview

The Visian Implantable Collamer Lens (ICL) is a safe and effective treatment option for patients who are unable to have LASIK or ASA.  The ICL is gently inserted into the eye. Once inside, the ICL bends the light to focus it perfectly onto the retina, similar to how a contact lens works on the surface of the eye. Unlike traditional contact lenses, the Visian ICL is positioned inside the eye between the iris (the colored part of the eye) and the natural lens, where it remains in place indefinitely without needing maintenance. However, the ICL can be removed in the future if necessary.

Because the ICL procedure does not require any reshaping of the corneal surface, it is a good choice for patients with irregular corneas or corneas that are not able to have laser surgery. It is also a good option for patients who are nearsighted beyond the range of treatment available with LASIK or ASA.

Because the Visian ICL is positioned between the iris and natural eye lens, the lens is invisible to both the patient and observers. Quick and painless, patients can usually expect a 10-20 minute procedure or less.

In addition to correcting vision, the Visian ICL creates a barrier of UV protection. The collamer material that makes up our ICLs have unique properties that provide UV protection, while allowing natural visible light pass through unaltered for sharp and precise vision.

Sharp, Clear Vision with ICL

  • Excellent Results – 99% satisfaction rate
  • Superb Night Vision
  • Quick Results – patients can achieve improved vision immediately following the procedure
  • Great for Thin Corneas – many patients are not candidates for vision correction, like LASIK because they have thin corneas, but now with Visian ICL, they can have vision correction and leave behind the hassles of glasses and contacts.  
  • Great for High Nearsightedness – ICL is able to correct and reduce myopia (nearsightedness) of up to -20D.

The recovery for the Visian ICL is quick and pain-free, and may be as little as one day. Patients typically experience minimal discomfort, and typically go back to work the very next day.

Learn more detailed information about FDA labeling for the technology mentioned here.